Navigation Links
Perrigo Reports Record Sales, Earnings and Cash Flow From Operations for Fiscal 2009
Date:8/18/2009

sic 92,183 93,124 92,230 Diluted 93,629 95,210 93,807 Dividends declared per share $0.215 $0.195 $0.178 (1) The sum of individual per share amounts may not equal due to rounding. PERRIGO COMPANY CONSOLIDATED BALANCE SHEETS (in thousands) June 27, June 28, Assets 2009 2008 ---- ---- Current assets Cash and cash equivalents $316,133 $318,599 Investment securities 3 560 Accounts receivable, net 325,810 317,875 Inventories 384,794 374,782 Current deferred income taxes 41,941 42,241 Income taxes refundable 8,926 10,215 Prepaid expenses and other current assets 23,658 36,951 Current assets of discontinued operations 51,699 58,968 ------ ------ Total current assets 1,152,964 1,160,191 Property and equipment Land 22,876 22,275 Buildings 262,990 254,030 Machinery and equipment 478,085 443,288 ------- ------- 763,951 719,593 Less accumulated depreciation (409,634) (381,053) -------- -------- 354,317 338,540 Restricted cash 400,000 400,000 Goodwill and other indefinite- lived in
'/>"/>
SOURCE Perrigo Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related medicine news :

1. Perrigo Company Announces Quarterly Dividend
2. Perrigo Company Will Release Fiscal Year 2009 Results on August 18, 2009
3. Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
4. Perrigo Receives FDA Approval to Market Cherry and Cinnamon Flavored Nicotine Lozenges
5. Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal(R) Solution and Announcement of Lawsuit by Sepracor/UCB
6. Perrigo Reports Record Third Quarter
7. Perrigo Company Announces Quarterly Dividend
8. Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
9. Perrigo Begins Shipments of Ibuprofen PM
10. Perrigo Reports Record Second Quarter Sales
11. Perrigo Company Announces Quarterly Dividend

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The molecular cause of inflammatory bowel d...esented at the upcoming 2009 Advances in Inflammat...s Foundation’s Clinical & Research Confe...y identify a causative mutation for Crohn’s ...Vocus) November 24, 2009 -- The molecular cause of...
(Date:11/24/2009)...s,Nov.24/PRNewswire/--NIP,Inc.todayannouncedtheacq...tion,sleadingexecutivecompensationandbenefitplanpr...ionalofficesinLosAngeles,Milwaukee,Boston,Chicagoa...enownedexpertintheexecutivebenefitsindustry. ,,...readyhassignificantmarketpresence,"statesBillPollo...
(Date:11/24/2009)...NO,Calif.,Nov.24/PRNewswire/--Nextmonth,UnitedHeal...edathelpingHispanic-Americanseniorsunderstandtheba...ragedtotakeafreeZumba®Goldclass,aLatin-infuse...a,cumbia,rumba,andtango. ,, UnitedHealthcarewil...ortableandengagedwhenlearningabouttheirhealthcareo...
(Date:11/24/2009)...Nov.24/PRNewswire/--TheUnionLaborLifeInsuranceComp...dwithVSP(®),()thenation,slargestvisionbenefit...ceproductstounions,uniontrustfunds,unionemployersa...tsofferingservicesincludingcomprehensiveeyeexams,b...howimportantqualityeyecareis,"statedBruceSmith,Nat...
(Date:11/24/2009)...lement may help ward off peripheral artery diseas...(HealthDay News) -- Among people aged 75 and older...vent heart attacks, stroke or death, a new study f... herbal remedy might help prevent the leg-circulat...wever. , Ginkgo contains nutrients called flavo...
Breaking Medicine News(10 mins):Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3
...ws Great for Moms and Babies, Bad for Mercury Fear...,seafood consumption guidelines for pregnant women...ers, Healthy Babies Coalition (HMHB), David,Martos...y swung back in the,direction of common sense. For...
...d Center for Geriatric Nursing Excellence in the U...r Hartford centers in the nation, have been funded... nurses have the most recent evidence-based guidel...ic Nursing Collaborative, are in the UI College of...
....J., Oct. 4 Understanding and Treating,Depression...ion produced by,the Multiple Sclerosis Association...ce on depression for both patients and families af...h topics as,the hidden symptoms of depression; war...
...7 National IPF Awareness Week on Capitol Hill Driv...dly Lung Disease, SAN JOSE, Calif., Oct. 4 The C...ced that the success of its fifth,annual National ...fibrosis (IPF), a progressive and ultimately fatal...
...on, wellness, and incentive system meets crucial n...et, FRANKLIN, Tenn., Oct. 4 Fontis Healthcare Se...d incentive support platform for,Group Health Savi...se of HSAs for employers, employees, and insurance...
...., Oct. 4 The following is a,statement regarding ...eople,store their health information online:, It ...le and other IT,leaders plan to develop personal h...Having ready access to your own,health information...
Other Medicine News:Health News:Consumer Group Statement on Seafood and Health: 'We Told You So' 2Health News:Multiple Sclerosis Association of America Publishes Booklet about Depression in Multiple Sclerosis 2Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 2Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 3Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 4Health News:Fontis Health Launches Online HSA Support System 2Health News:Statement Regarding Microsoft's Announcement of New Services to Help People Store Their Health Information Online 2
(Date:11/24/2009)..., MISSISSAUGA,Ontario,Nov.24/PRNewswire-FirstCall/...adeveloperoftechnologyandproductstargetingtheimmun...kChimieS.A.S.("MerckChimie")isprogressingtothenext...arysilvercoatedparamagneticBeads("Beads"). ,, P...rthisyear,CardioGenicssuppliedMerckChimiewithitspr...
(Date:11/24/2009)..., FRANKLIN,Mass.,Nov.24/PRNewswire-FirstCall/--Ech...developingitsneedle-freeSymphony(TM)tCGMSystemasan...onitoring(tCGM)systemanditsPrelude(TM)SkinPrepSyst...rickT.Mooney,M.D.,ChairmanandChiefExecutiveOfficer...maceuticalsConference,sponsoredbytheNewYorkSociety...
(Date:11/24/2009)..., NORTHHOLLYWOOD,Calif.,Nov.24/PRNewswire-FirstCal...leadingnationalhospitalistphysiciangrouppracticeco...IPChospitalist,wasnamedby ACPHospitalist asoneofth...intheNovember2009issueofthemagazine. ,, Dr.Vaid...dcurrentlyservesasdirectorofhospitalmedicineatSt.M...
Breaking Medicine Technology:CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2Cell Biosciences Completes Acquisition of Alpha Innotech 5802 1Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference 5797 1Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference 5797 2Gene Variants Behind Vulnerability to Yeast Infections 60280 1Gene Variants Behind Vulnerability to Yeast Infections 60280 2Gene Variants Behind Vulnerability to Yeast Infections 60280 3
...ng CIMZIA,s long-term benefits and value in,modera... American College,of Gastroenterology (ACG), ORLA...this week by UCB at the American College of Gastro...IMZIA(R) (certolizumab pegol) - the,only PEGylated...ovides,sustained improvement in symptoms with stab...
... 7 , - 125 Patient, Prospective Randomized Placeb...gnificant Improved Overall Survival, Bavarian Nor...m the,therapeutic prostate cancer vaccine candidat...he recently entered partnership with the National,...om the Phase II prospective randomized placebo-con...
Other Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5
...UHTS), Analyst GT delivers unsurpassed multimode a...sfer of assays into screening from assay developme...yst AD and HT, fluorescence intensity, fluorescenc...scence, absorbance, as well as providing seamless ...
...Analyst HT smoothes the transfer of assays into HT...y performance of Analyst AD, fluorescence intensit...cence, luminescence, absorbance. Optimized for se...uding those from Beckman Coulter, Zymark, CRS and ...
...lopment and basic research, including a simple ins...ime required to move assays into HTS. Specifically...ment laboratories, Analyst AD delivers unparallele..., Fluorescence Polarization, Time-Resolved Fluores...
...oplate based multi-detection reader which incorpor...orescence Polarization , Fluorescence Intensity ,...minescence (flash and glow) , Absorbance ,It i...dioactive labeled applications:, , Ca2+ Measuremen...
Medicine Products: